Inherited cardiomyopathies associated with AF . | |||
---|---|---|---|
Cardiac abnormality | Genetic defect | … found in | AF prevalence (rough estimate) |
Brugada syndrome | Loss-of-function SCN5A mutations (10–15% of patients) | Familial clusters | 10–20% |
Long QT syndrome | Late gain-of-function SCN5A and loss-of-function K channel mutations, among others | Familial clusters | 5–10% |
Short QT syndrome | Gain-of-function K channel mutations | Familial clusters | 70% |
Catecholaminergic VT | Loss-of-function ryanodine receptor mutation | Rare families | |
Hypertrophic cardiomyopathy | Sarcomeric proteins | Unselected patient cohorts | 5–15% |
Wolff–Parkinson–White syndrome and abnormally LVH | PRKAG mutations | Family clusters | |
Holt–Oram syndrome with AF | TBX5 mutations (regulatory gene) | Family clusters |
Inherited cardiomyopathies associated with AF . | |||
---|---|---|---|
Cardiac abnormality | Genetic defect | … found in | AF prevalence (rough estimate) |
Brugada syndrome | Loss-of-function SCN5A mutations (10–15% of patients) | Familial clusters | 10–20% |
Long QT syndrome | Late gain-of-function SCN5A and loss-of-function K channel mutations, among others | Familial clusters | 5–10% |
Short QT syndrome | Gain-of-function K channel mutations | Familial clusters | 70% |
Catecholaminergic VT | Loss-of-function ryanodine receptor mutation | Rare families | |
Hypertrophic cardiomyopathy | Sarcomeric proteins | Unselected patient cohorts | 5–15% |
Wolff–Parkinson–White syndrome and abnormally LVH | PRKAG mutations | Family clusters | |
Holt–Oram syndrome with AF | TBX5 mutations (regulatory gene) | Family clusters |
Gene defects associated with AF . | |||
---|---|---|---|
Type of AF | Genetic defect identified | … found in | Associated with AF in |
‘Lone’ AF | Loss-of-function SCN5A mutations | ‘Lone’ AF cohorts | 5% of ‘lone’ AF patients |
AF and heart failure | SCN5A mutation | One large family | Rare forms |
‘Lone’ AF | Gain-of-function K channel mutations | Single families | Rare families, associated with short QT syndrome |
‘Lone’ AF | Loss-of-function K channel polymorphisms | Large association study | Rare families, associated with long QT syndrome |
‘Lone’ AF | Loss-of-function Kv1.5 mutation (IKur) | Selected patients | Rare patients |
‘Lone’ AF | Somatic connexion 40 mutations | Unrelated patients | Not known (requires atrial tissue for testing)s |
‘Lone’ AF | Frameshift (loss-of-function) ANP mutation | Familial clustering | Not known |
All types of AF | PITX2 polymorphism (involved in pulmonary and cardiac development) | Genome-wide association | Populations (Iceland and elsewhere) |
Gene defects associated with AF . | |||
---|---|---|---|
Type of AF | Genetic defect identified | … found in | Associated with AF in |
‘Lone’ AF | Loss-of-function SCN5A mutations | ‘Lone’ AF cohorts | 5% of ‘lone’ AF patients |
AF and heart failure | SCN5A mutation | One large family | Rare forms |
‘Lone’ AF | Gain-of-function K channel mutations | Single families | Rare families, associated with short QT syndrome |
‘Lone’ AF | Loss-of-function K channel polymorphisms | Large association study | Rare families, associated with long QT syndrome |
‘Lone’ AF | Loss-of-function Kv1.5 mutation (IKur) | Selected patients | Rare patients |
‘Lone’ AF | Somatic connexion 40 mutations | Unrelated patients | Not known (requires atrial tissue for testing)s |
‘Lone’ AF | Frameshift (loss-of-function) ANP mutation | Familial clustering | Not known |
All types of AF | PITX2 polymorphism (involved in pulmonary and cardiac development) | Genome-wide association | Populations (Iceland and elsewhere) |
ANP, atrial natriuretic peptide; LVH, left ventricular hypertrophy.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.